Posted by Latisha Jones on Feb 6th, 2026
Shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Get Free Report) have received an average rating of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat reports. One investment analyst...
More of this article »